Momenta Pharmaceuticals, Inc. (MNTA)

[floblu14]

Two new EPO applications regarding Novel drugs -

COMPOSITIONS AND METHODS RELATED TO ENGINEERED FC-ANTIGEN BINDING DOMAIN CONSTRUCTS 2018-7-12

Abstract:
The present disclosure relates to compositions and methods of engineered Fc-antigen binding domain constructs, where the Fc-antigen binding domain constructs include at least two Fc domains and at least one antigen binding domain.

https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20180712&CC=WO&NR=2018129397A1&KC=A1

COMPOSITIONS AND METHODS RELATED TO ENGINEERED FC CONSTRUCTS 2018-7-12

Abstract:
The present disclosure relates to engineered IgG Fc constructs and uses thereof.

https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=1&ND=3&adjacent=true&locale=en_EP&FT=D&date=20180712&CC=WO&NR=2018129255A1&KC=A1